Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M81,503Revenue $M25,589Net Margin (%)4.7Altman Z-Score2.1
Enterprise Value $M88,033EPS $0.5Operating Margin %8.1Piotroski F-Score4
P/E(ttm)68.9Beneish M-Score-2.8Pre-tax Margin (%)4.3Higher ROA y-yN
Price/Book4.510-y EBITDA Growth Rate %4.9Quick Ratio0.7Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %-16.1Current Ratio0.9Lower Leverage y-yN
Price/Free Cash Flow39.9y-y EBITDA Growth Rate %-30.7ROA % (ttm)2.2Higher Current Ratio y-yN
Dividend Yield %4.3PEG--ROE % (ttm)6.3Less Shares Outstanding y-yN
Payout Ratio %300Shares Outstanding M2,528ROIC % (ttm)8.2Gross Margin Increase y-yN

Gurus Latest Trades with AZN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AZNDavid Dreman 2015-06-30 Sold Out -0.16%$31.86 - $36.68
($34.23)
$ 32.24-6%Sold Out0
AZNNWQ Managers 2015-06-30 Add0.12%$31.86 - $36.68
($34.23)
$ 32.24-6%Add 486.45%306,510
AZNMario Gabelli 2015-06-30 Reduce$31.86 - $36.68
($34.23)
$ 32.24-6%Reduce 28.81%8,400
AZNDavid Dreman 2015-03-31 Reduce-0.01%$32.22 - $36.35
($34.74)
$ 32.24-7%Reduce 4.43%54,978
AZNNWQ Managers 2015-03-31 Reduce-0.01%$32.22 - $36.35
($34.74)
$ 32.24-7%Reduce 21.34%104,530
AZNMario Gabelli 2015-03-31 Reduce$32.22 - $36.35
($34.74)
$ 32.24-7%Reduce 40.70%23,600
AZNDavid Dreman 2014-12-31 Reduce-0.51%$33.58 - $37.69
($35.81)
$ 32.24-10%Reduce 75.42%57,528
AZNGeorge Soros 2014-12-31 Sold Out -0.08%$33.58 - $37.69
($35.81)
$ 32.24-10%Sold Out0
AZNMario Gabelli 2014-12-31 Reduce-0.01%$33.58 - $37.69
($35.81)
$ 32.24-10%Reduce 52.51%39,800
AZNNWQ Managers 2014-12-31 Add$33.58 - $37.69
($35.81)
$ 32.24-10%Add 3.05%132,880
AZNCharles Brandes 2014-09-30 Sold Out -0.35%$34.25 - $38.16
($36.6)
$ 32.24-12%Sold Out0
AZNMario Gabelli 2014-09-30 Add$34.25 - $38.16
($36.6)
$ 32.24-12%Add 3.71%83,800
AZNDavid Dreman 2014-09-30 Reduce$34.25 - $38.16
($36.6)
$ 32.24-12%Reduce 0.70%234,006
AZNCharles Brandes 2014-06-30 Reduce-0.78%$31.23 - $40.55
($36.09)
$ 32.24-11%Reduce 71.06%772,116
AZNJoel Greenblatt 2014-06-30 Sold Out -0.09%$31.23 - $40.55
($36.09)
$ 32.24-11%Sold Out0
AZNDavid Dreman 2014-06-30 Reduce-0.09%$31.23 - $40.55
($36.09)
$ 32.24-11%Reduce 13.00%235,664
AZNGeorge Soros 2014-06-30 Buy 0.08%$31.23 - $40.55
($36.09)
$ 32.24-11%New holding300,000
AZNMario Gabelli 2014-06-30 Buy 0.02%$31.23 - $40.55
($36.09)
$ 32.24-11%New holding80,800
AZNNWQ Managers 2014-06-30 Reduce-0.01%$31.23 - $40.55
($36.09)
$ 32.24-11%Reduce 24.55%128,950
AZNHOTCHKIS & WILEY 2014-03-31 Sold Out -0.93%$29.26 - $34.19
($32.29)
$ 32.24-0%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AZN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ASTRAZENECA PLC10% Owner 2014-11-12Sell2,000,000$1786.35view

Quarterly/Annual Reports about AZN:

    News about AZN:

    Articles On GuruFocus.com
    Francis Chou Doubles Stake in AstraZeneca Aug 11 2015 
    Last Month Insiders Bought Over $300 Million Of This Biotech Jun 26 2015 
    Guru Stocks at 52-Week Lows: XOM, WMT, CVX, AZN, COP Jun 21 2015 
    Amgen And AstraZeneca’s Deal On Psoriasis Drug Faces Termination May 27 2015 
    Johnson & Johnson A Good Investment Despite Current Lows May 14 2015 
    Vanguard Adds to Four of Its Largest Stakes May 04 2015 
    HealthCare Stocks That Can Make Investors Healthier Apr 08 2015 
    Regulus Therapeutics (RGLS) microRNA Therapeutic Milestone Payment, Dave & Buster's Entertainment (P Apr 08 2015 
    Pfizer Stocks Has A Lot Of Steam To Take The Investors Higher Jan 20 2015 
    Merck Takes A Step Forward In The World Of Medicine Jan 16 2015 

    More From Other Websites
    AstraZeneca and Heptares Therapeutics enter agreement to develop novel immuno-oncology treatments Sep 02 2015
    AstraZeneca Strikes Deal with Valeant for Psoriasis Drug Sep 02 2015
    FTSE closes positive, follows Wall Street gains Sep 02 2015
    Broker tips: RBS, ARM Holdings, Astrazeneca Sep 02 2015
    Broker tips: RBS, ARM Holdings, Astrazeneca Sep 02 2015
    Positive Phase III results demonstrate efficacy of antibiotic medicine CAZ-AVI in complicated... Sep 02 2015
    Allergan Announces FDA Approval of Updated Label for TEFLARO® (ceftaroline fosamil) Sep 02 2015
    AstraZeneca plc In New Partnership With Controversial Valeant Pharmaceuticals Intl Inc Sep 02 2015
    AstraZeneca lifted by HSBC upgrade to 'buy' Sep 02 2015
    4:48 am AstraZeneca enters license agreement to develop FluMist in Japan Sep 02 2015
    Britain's FTSE edges higher, buoyed by Ashtead and pharma Sep 02 2015
    AstraZeneca enters license agreement with Daiichi Sankyo for development and commercialisation of... Sep 02 2015
    Overheard: Focus-Enhancing Drugs Sep 01 2015
    Valeant steps in to work on psoriasis drug with AstraZeneca Sep 01 2015
    Valeant steps in to work on psoriasis drug with AstraZeneca Sep 01 2015
    FTSE 100 falls as miners slump on weak China data Sep 01 2015
    Valeant Buys Abandoned AstraZeneca Psoriasis Drug Sep 01 2015
    Valeant Strikes Psoriasis-Drug Pact With AstraZeneca Sep 01 2015
    Apple original content; Dollar Tree profit miss; Penn West cuts; Whirlpool bid Sep 01 2015
    Stocks slammed; Fed rate hike in limbo?; Hedge funds pounded Sep 01 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK